Chelation refers to a type of bonding of ions and molecules to metal ions. The process describes a chemical reaction in which certain molecules bind to metal atoms, such as arsenic, calcium, copper, iron, lead, or mercury.
Chelating drugs bind with metals so that they can be excreted from the body. Such drugs are commonly used in conventional medicine to treat iron overdoses, lead poisoning, and other heavy metal poisonings. Practitioners of chelation therapy believe that many disorders are the result of excessive metal in the body even when the patient was not exposed to the metal and blood tests do not show high levels of metal. For that reason, chelation therapists may treat several disorders with chelating drugs.
Thus, while chelation therapy is used in conventional medicine for the treatment of metal poisoning, it is also used as an alternative treatment option for other conditions, such as heart disease, Alzheimer's disease, autism, multiple sclerosis, and other health problems.
In chelation therapy, a chelating agent is introduced into the body through an intravenous drip or oral pill. After entering the bloodstream, the chelating agent binds to certain molecules, such as metals or minerals, taking them with it after urination removes them from the body.
Common chelating agents include EDTA (diamine tetra-acetic acid), which is used to remove calcium, copper, iron, and lead from the blood, as well as Dimercaprol (arsenic, copper, gold, mercury), Succimer (arsenic, cadmium, lead, mercury), Deferoxamine (copper, zinc), Penicillamine (copper), and Deferasirox (copper, lead, zinc).
Although the FDA has only approved prescription chelation therapy for metal poisoning, it is used for the treatment of other ailments in alternative medicine. However, chelation therapy for uses other than metal toxicity is not taught in conventional medical schools, and practitioners who use it for other purposes are known as naturopathic, or alternative medical, practitioners.
Side effects that have been attributed to chelation therapy are most common when high doses are used, and may include abdominal pain, diarrhea, fatigue, flu-like symptoms, gastrointestinal disorders, headaches, high blood pressure, low blood pressure, seizures, vomiting, and weight loss. In some cases, the therapy can trigger more serious side effects, including dehydration and kidney damage.
Recommended Resources
Created in 2003, Angioprim is designed to remove rogue calcium molecules and fatty cholesterol deposits, known as plaque, from the circulatory system through chelation. Designed to help with angina, arterial plaque, atherosclerosis, angioplasty, congestive heart failure, bone spurs, and diabetes. Available Angioprim packages are promoted here, with descriptions and prices, as well as online shopping. Customer testimonials, affiliates, contacts, and informational articles are included.
https://angioprim.com/
The Biosanctuary is a private retreat facility in Sedona, Arizona. The facility offers a 7-day BioClear Radical Transformation package that includes individualized detoxification and chelation programs, including laboratory testing, adjuvant therapies, superfoods, and program materials provided during treatment, as well as a 7-day NeuroClear neurodegenerative rejuvenation package, which includes a series of intensive therapies, which are highlighted here. Its location and contacts are posted.
https://thebiosanctuary.com/
Located in Ontario, Canada, Cardio Renew is an oral chelation product used to remove calcium, as well as other minerals and heavy metals from the body, resulting in clean arteries, the objective being to increase blood flow, thus providing the tissues, organs, nerves, and other body systems with oxygen and nutrients. Product information, packages, and comparisons with other chelation therapies are given, along with other product information and promotional videos.
https://cardiorenewcanada.ca/
Chelation Medical Centers of the Okanagan
Dr. D. Wittel is a licensed medical doctor who practices holistic medicine, specializing in intravenous chelation therapy in the treatment of hardening of the arteries and degenerative diseases. An introduction to Dr. Wittel is provided, along with an overview of chelation therapy, written by Dr. Wittel, a testimonial from a Doctor of Vascular, Thoracic and General Surgery, and information about various IV therapies. Locations, hours, and contacts are posted.
https://chelationbc.com/
EDTA Chelation removes metals from the circulatory system, the concept being that the body has a need for about seventy trace element heavy metals, but there are another twelve poisonous heavy metals, such as aluminum, arsenic, cadmium, lead, mercury, and nickel, which act as poisonous interference to the enzyme systems or procedures one takes, with heavy metal overload being a detriment to the natural healing functions of the body. EDTA research and information about chelation is offered.
https://edta.net/
Offering IV chelation (EDTA) treatments in central Indiana since 2012, the physician-supervised clinic uses up-to-date protocols in the administration of IV EDTA treatments, which may be used in the treatment of heart disease, cerebrovascular disease, high blood pressure, heavy metal toxicity, metal build up after chemotherapy, and peripheral vascular disease. Its address, hours, and contacts are published on the site, along with information about chelation therapy and the clinic.
http://indychelation.com/
Omaha Health and Therapy Center
The Center takes a holistic and integrative approach to medicine, combining conventional and supportive cancer treatments to prevent and treat disease, optimize patient health and wellness, and offer supportive cancer treatments. Certified in chelation therapy by the American College of Advancement in Medicine, as well as IV nutrition therapy, and Prolozone injections by the American Academy of Ozonotherapy, Sarah Kracht is a member of the American Academy of Anti-Aging Medicine.
https://www.chelationomaha.com/
Trial to Assess Chelation Therapy 2
Chelation refers to the administration of chelating agents to remove heavy metals from the body. TACT1, the first trial to assess chelation therapy was developed in response to a request from the National Center for Complementary and Alternative Medicine and the National Heart Lung and Blood Institute, and was completed in 2012. As a result of the TACT1 findings, the National Institutes of Health and the Federal Drug Administration requested TACT2 in order to confirm the results.
https://tact2.org/
